Component
Cyanidin 3,5-O-diglucoside / cyanin
Cyanidin 3,5-O-diglucoside / cyanin. Interpret through the linked experimental species, preparation, compartment and exposure; no universal causal effect is implied.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The tested cyanidin glycoside reduced fluorescent glucose-analogue uptake in Caco-2 BBe1 cells at 50 uM.
Experimental context and source evidence
- evidence_access
- Full text retrieved; relevant methods/results/figure text reviewed. No independent raw-data verification.
- experimental_contrast
- {"intervention": "50 uM cyanidin-3-5-diglucoside", "comparator": "Cell assay without added glycoside", "endpoint": "The tested cyanidin glycoside reduced fluorescent glucose-analogue uptake in Caco-2 BBe1 cells at 50 uM.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Human Caco-2 BBe1; 50 uM flavonoid pretreatment, fluorescent 2-NBDG uptake; not dietary human glucose absorption.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Fluorescent analogue outcome, not verified clinical glycemic benefit or carbohydrate deficiency.
- plain_language
- The tested cyanidin glycoside reduced fluorescent glucose-analogue uptake in Caco-2 BBe1 cells at 50 uM.
- primary_references
- Molecular Mechanisms Underlying the Absorption of Aglycone and Glycosidic Flavonoids in a Caco-2 BBe1 Cell Model. | 2020 | DOI 10.1021/acsomega.0c00379 | PMID 32455198 | https://pubmed.ncbi.nlm.nih.gov/32455198/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC7240828/ | https://doi.org/10.1021/acsomega.0c00379
- source_locator
- Reviewed reference lines 40-40; exact primary location described in quoted passage where extracted.
Anthocyanins: detailed mechanisms of action (reviewed 4 October 2026) · lines 40–40
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Human Caco-2 BBe1; 50 uM flavonoid pretreatment, fluorescent 2-NBDG uptake; not dietary human glucose absorption. · source_derived_draft · unverified_draft
**Glucose handling is a separate cross-nutrient interaction.** A Caco-2 BBe1 study tested cyanidin and glycosides alongside quercetin compounds. At 50 µM, the glycosides reduced uptake of the fluorescent glucose analogue 2-NBDG. Transport inhibition and SGLT1 knockdown supported carrier involvement in glycoside uptake, with different behavior for aglycones. This is a nutrient-transport interaction in cultured cells; it is not proof that ordinary berry intake blocks intestinal glucose absorption or causes carbohydrate deficiency. [Zhang et al., 2020, transport and glucose-uptake experiments](https://pmc.ncbi.nlm.nih.gov/articles/PMC7240828/).
Complete structured claim and evidence
What acts on it
The anthocyanin class includes Cyanidin 3,5-O-diglucoside / cyanin; membership does not transfer experimental effects.
Experimental context and source evidence
- evidence_access
- Full text retrieved; relevant methods/results/figure text reviewed. No independent raw-data verification.
- experimental_model
- Chemical classification, not an intervention or efficacy result.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Glycosides remain separate from aglycones and from each other. This neutral identity record is navigation, not a signed causal mechanism.
- plain_language
- The anthocyanin class includes Cyanidin 3,5-O-diglucoside / cyanin; membership does not transfer experimental effects.
- primary_references
- Molecular Mechanisms Underlying the Absorption of Aglycone and Glycosidic Flavonoids in a Caco-2 BBe1 Cell Model. | 2020 | DOI 10.1021/acsomega.0c00379 | PMID 32455198 | https://pubmed.ncbi.nlm.nih.gov/32455198/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC7240828/ | https://doi.org/10.1021/acsomega.0c00379
- source_locator
- Reviewed reference lines 7-7; exact primary location described in quoted passage where extracted.
Anthocyanins: detailed mechanisms of action (reviewed 4 October 2026) · lines 7–7
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Chemical classification, not an intervention or efficacy result. · source_derived_draft · unverified_draft
Anthocyanins are a class of glycosylated pigments, not one circulating drug. Their anthocyanidin cores include cyanidin, delphinidin, pelargonidin, peonidin, petunidin and malvidin. Sugar position, sugar identity, methylation and acylation change their behavior. Cyanidin, cyanidin-3-O-glucoside, cyanidin-3-O-galactoside and cyanidin-3,5-O-diglucoside are separate molecules. Nasunin is a distinct acylated delphinidin glycoside; it must not inherit every result obtained with cyanidin-3-glucoside. The tested aglycones and glycosides illustrate why the individual structures matter. [Purified-compound comparison](https://pmc.ncbi.nlm.nih.gov/articles/PMC7541926/).
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.